The world has seen Sabrina Carpenters skin her daughter pale skin.
The child, who was born on Sunday, is in a critical condition.
Sabrina Carpenter is now facing a lot of questions about why she chose to go to the hospital in the first place.
She was rushed to the emergency room in Jerusalem and was declared clinically dead on arrival.
“I did not feel I needed to do this.
I was so scared that she would die,” said Sabrina’s mother, Sabrina.
“I have to look at her now to see if she can breathe and if she is breathing.”
It’s a story that has drawn the attention of many and led to speculation that Sabrina was suffering from a rare genetic condition known as the epidermolysis bullosa (EB), which is known to cause severe skin damage.
“She is very fragile.
She is not very well,” said her mother, who did not want to be named for fear of reprisal from the family.”
We are afraid she might have to be sent to the morgue,” she added.
On Monday, Israel’s Health Ministry announced that Sabina had EB and had been given a diagnosis of “epidermocytic encephalomyelitis” or EBI.
The diagnosis is rarely made in Israel, and doctors are not sure if it is related to the skin condition.
The condition has been linked to an increase in EB cases in Israel since the late 1970s, with many parents concerned about their babies’ health.
“It was difficult for us to believe we had a case, but it was a possibility,” said Dr. Eran Mazor, who is the director of the EBA Center for Children’s Diseases at Ben-Gurion University Medical Center.
“It was a big shock for me when I saw it.”
Mazor believes that if he had known that the child was EB, he would have stopped her from having surgery.
“I would have had to have had her transferred to a different hospital in Israel.
I do not want her to die in Israel,” he said.
The Israeli government has offered a variety of measures to control the EB epidemic, including limiting the number of parents who can have children in the country.
Mazor believes this should be done more than ever, to stop the spread of EB.
“Every day that goes by, we have more EB cases,” he explained.
“The government is doing everything to get it under control.”
In addition to a large amount of medical resources, there is also an increase of international pressure, with governments around the world calling for Israel to stop importing EB products.
“This is a very dangerous epidemic and we have to do everything to stop it from spreading,” said Mazor.
However, even with these precautions, the EB rate in Israel has remained stubbornly high, despite the number and severity of EB cases.
The number of EB patients has increased in recent years, from 1,600 in 2009 to 3,600 this year.
The situation is expected to continue to worsen.
Israel has been one of the few countries that continues to import EB products from the United States, but Mazor said that has only increased the risk for the EB cases that are being imported.
“There are many more EB patients in Israel and they are being treated in hospitals that have not been properly trained to deal with EB,” he added.
“If we do not intervene, there will be another wave of EB in Israel.”
“It’s time for Israel and the world to start looking seriously at our EB cases and start a national conversation about how we treat our EB patients,” Mazor concluded.
(H/t: Haaretz) Subscribe to our newsletter